Kevin Kalinsky, MD, MS, FASCO, notes insights from a molecular tumor board discussion about the optimal management of HR-positive metastatic breast cancer.
Back
Dr Kalinsky on Multidisciplinary Considerations for ESR1+ Breast Cancer Care
Dr Kalinsky on Multidisciplinary Considerations for ESR1+ Breast Cancer Care
Episodes
All
All
Kevin Kalinsky, MD, MS, FASCO, notes the advantages of collaborating with multidisciplinary tumor boards when managing metastatic breast cancer.
Kevin Kalinsky, MD, MS, FASCO, discusses the role of integrative oncology programs and the importance of survivorship clinics within cancer care.
Advertisement
Advertisement
Trending on OncLive
1
Dr Pant on the Potential Significance of Daraxonrasib for PDAC Management
2
Dr Akhade on Building the Evidence Base for Low-Dose Immunotherapy
3
FDA Accepts NDA for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer
4
EGFR PACC Mutations Define a Distinct NSCLC Subclass With Growing Treatment Options
5